Health & Medicine

STAT+: Pharmalittle: We're reading about TrumpRx shortcomings, Lilly targeting employers, and more

31 sec read243 views0 listens

President Trump's drug discount platform, TrumpRx, has fallen short of expectations a month after launch, with limited availability and usage data, contrasting sharply with its promised impact on reducing medication costs. The FDA’s top drug regulator is pushing to add new warnings about pregnancy risks to antidepressants, reflecting ongoing debates over drug safety and labeling. For content creators, these developments highlight the importance of critically evaluating health policy claims and staying informed about regulatory changes affecting pharmaceuticals.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Tech & GadgetsMar 2730 sec read

Outbreak linked to raw cheese grows; 9 cases total, one with kidney failure

The Food and Drug Administration has identified two additional cases in an E. coli outbreak linked to unpasteurized cheese and milk from Raw Farm, bringing the total to nine sickened individuals across three states, with one case developing kidney fa...

Ali Nemati

Health & MedicineMar 2727 sec read

STAT+: Amid focus on food, FDA leader briefs lawmakers on priorities

The FDA has outlined plans for 2026 focusing on infant formula safety, food labeling updates, defining ultra-processed foods, enhanced inspections of processing plants, and improved seafood safety programs. These priorities signal a shift in health p...

Ali Nemati

Health & MedicineMar 1024 sec read

Leucovorin lacks evidence to use as autism treatment, FDA says

The FDA approved leucovorin for treating cerebral folate deficiency but clarified there's insufficient evidence to support its use as an autism treatment, retracting previous statements suggesting broad benefits for autistic children. This decision u...

Ali Nemati